Zum Hauptinhalt springen

Hepatitiden

27. Oktober 2017 | Hepatitiden

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review Dr Sarah Larney, Amy Peacock, PhD, Janni Leung, Samantha Colledge, Prof Matthew Hickman, Prof…

22. Oktober 2017 | Hepatitiden

Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis.

Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis. Wijarnpreecha K, Chesdachai S, Jaruvongvanich V, Ungprasert P. Eur J Gastroenterol Hepatol. 2017 Oct 18. doi: 10.1097/MEG.0000000000000991. Abstr…

19. Oktober 2017 | Hepatitiden

Response to the Cochrane systematic review on DAA-based treatment of chronic hepatitis C

Response to the Cochrane systematic review on DAA-based treatment of chronic hepatitis C European Association for the Study of the Liver Journal of Hepatology , Volume 67 , Issue 4 , 663 - 664 , doi.org/10.1016/j.jhep.2017.06.022 http://www.journ…

19. Oktober 2017 | Hepatitiden

Direct-acting antivirals for chronic hepatitis C. (Cochrane review)

Direct-acting antivirals for chronic hepatitis C. (Cochrane review) Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Glu…

19. Oktober 2017 | Hepatitiden

Hepatitis C: Cochrane-Review stellt DAA-Therapie in Frage – Hepatologen kritisieren „sinnlos“ und „schlecht gemacht“

Die Therapie einer Hepatitis-C-Infektion mit direkten antiviralen Agenzien (DAA) kann das Virus schon nach einer Therapiedauer von 8 bis 12 Wochen dauerhaft eliminieren, was Hepatologen nach bisherigem Verständnis als Heilung betrachten. Ein Re…

19. Oktober 2017 | Hepatitiden

SMFM Consult Series #43, Hepatitis C in pregnancy: screening, treatment, and management

SMFM Consult Series #43, Hepatitis C in pregnancy: screening, treatment, and management Society for Maternal-Fetal Medicine (SMFM) Brenna L. Hughes, Charlotte M. Page, Jeffrey A. Kuller, MD American Journal of Obstetrics & Gynecology, articl…

19. Oktober 2017 | Hepatitiden

Leading medical organizations issue recommendations regarding hepatitis C in pregnancy

High-risk pregnancy experts published eight specific recommendations for screening, treatment and management of hepatitis C in pregnancy. (Society for Maternal-Fetal Medicine, USA, 19.10.2017) https://www.eurekalert.org/pub_releases/2017-10/sfmm-lm…

Weitere
akutelle Informationen
zu den Themengebieten